Jonathan Lewis, MD, PhD

Media Releases

Where Precision Meets Impact: Pioneering Immunotherapies that Revolutionize Cancer Treatment

Dr. Jonathan Lewis has joined Syncromune as the Chief Strategy Officer, bringing his wealth of experience in cancer research and immunotherapies to lead the development of an innovative in situ platform therapy for metastatic solid tumor cancers. Syncromune, a clinical-stage biopharmaceutical company, aims to revolutionize cancer treatment with high response rates and potentially improved survival outcomes.

With a distinguished career in global translational and clinical research, Dr. Lewis has held key leadership positions at renowned biopharmaceutical companies. As the former Executive Chairman, CEO, and Chief Medical Officer of Ziopharm Oncology, he spearheaded the development of groundbreaking immunotherapies for metastatic cancers. Prior to that, he served as Chairman and Chief Medical Officer of Antigenics, Inc, focusing on personalized therapeutic vaccines for various diseases.

Dr. Lewis is a highly respected figure in the medical and scientific community, serving as Chairman of three boards and Director of two others. His educational background includes an M.D. from Witwatersrand University and a Ph.D. from Yale University, with additional training at esteemed institutions such as The Royal College of Surgeons in Edinburgh, Cambridge University, and Memorial Sloan-Kettering Cancer Center.

At Memorial Sloan-Kettering Cancer Center in New York, Dr. Lewis made significant contributions as an attending surgeon in the Department of Surgery and as an attending physician in the Clinical Immunology Service, Division of Hematologic Oncology. He also held a professorship at Weill Medical College of Cornell University, and currently serves as an Adjunct Professor at Lankenau Institute for Medical Research.

Recognized for his exceptional leadership and fundraising abilities, Dr. Lewis has raised over 1 billion US dollars in equity, nonprofit, and government funding. His achievements have been acknowledged with prestigious honors and awards in medicine and science, including the ASCO Young Investigator Award, the Kristen Carr Fellowship, the Yale University Ohse Fellowship, the Royal College of Surgeons Trubshaw Medal, the University of Cambridge Churchill Fellowship, the inaugural Kristen Ann Carr Fellowship, and the Sarcoma Foundation of America Hope and Vision Award. His extensive research has led to over 200 scientific publications and contributions to numerous textbooks in the field of cancer biology and treatment.

Syncromune is thrilled to welcome Dr. Jonathan Lewis to its team as Chief Strategy Officer, confident that his expertise and vision will drive the company towards developing innovative cancer therapies that have the potential to transform patient outcomes.

Recommended Articles

• What Are the Symptoms of Testicular Cancer?

  Testicular cancer is rare when compared to other forms of cancer. This cancer develops in one or both testicles in men, particularly among men in the between the ages of 20-years-old and 40-years-old. It may be seen in elderly men as well. In the past few decades, the number of people affected by...

• Student Makes Potential Breakthrough in Breast Cancer Treatment

  New treatments make waves in the media frequently. Diseases affect everyone in one way or another. This makes them feel scary and unsolvable. Research is the light at the end of the tunnel that gives us a glimmer of hope. However, it is rarer for a treatment to become a breakthrough for a...

• Husband and Wife Battle Breast Cancer Together

  A South Florida couple face the most difficult challenge of their marriage after both being diagnosed with breast cancer. Read on to learn more.Breast cancer is not a disease that affects just women. In men, there is a small amount of breast tissue containing several ducts that reside just under the...

• The Best Ways to Discuss Diagnosis

  Every woman handles the early days after her breast cancer diagnosis and prognosis a little differently. Some women want to rush out and tell the world. For these women, just telling anyone makes the load seem a little lighter. Somehow when they share their troubles, it almost feels as though the...

• When Should I Get Checked for Prostate Cancer?

  Prostate cancer is more likely to occur in men aged between forty and seventy years old. It is, therefore, important that you should always be on alert in case any symptoms begin to show. This prompts a visit to the doctor within the quickest possible time.Deciding on whether or not to be screened...

• Tips on Living with Leukemia

  Leukemia is defined as the cancer of blood or bone marrow which is responsible for the production of blood cells. A person who has leukemia generally suffers from an abnormal production of blood cells specially leukocytes, also known as white blood cells, that are responsible to protect the body...